In brief: Regenera, Compumedics, SciGen
Friday, 21 October, 2005
Regenera (ASX:RGA) has appointed Hon Dr Michael Woodridge as non-executive chairman effective immediately, subject to shareholder approval. Woodridge is a former federal minister for health and is currently chairman of Neurosciences Australia, the Cooperative Research Centre in Oral Health Science, Resonance Health (ASX:RHT), Dia-B (ASX:DIA) and a board member of Cogstate (ASX:CGS), Research Australia and the Centre for Eye Research Australia.
Koichiro Koike has resigned as a director of Compumedics (ASX:CMP) due to health reasons. The company has yet to decide on a replacement and when that will occur.
Dr Colin Goldschmidt and Chris Wilks will today step down as directors of SciGen (ASX:SIE) due to their time commitments to Sonic Healthcare, a company which spun out of SciGen in 2002.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
